Suturing vs Biological Adhesive in Simple Lacerations of Hand (sutvsglu)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00524888
First received: September 4, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted

September 4, 2007
September 4, 2007
September 2007
Not Provided
Wound appearance [ Time Frame: 3 Months ]
Same as current
No Changes Posted
pain of treatment and time length of treatment [ Time Frame: 3 months ]
Same as current
Not Provided
Not Provided
 
Suturing vs Biological Adhesive in Simple Lacerations of Hand
Suturing Vs Adhesion for Hand Lacerations in the ER A Randomized Prospective Study

To assess the difference in clinical outcome between lacerations in the hand treated by sutures versus treated by tissue adhesive.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Lacerations
  • Procedure: suturing laceration
    suturing simple lacerations of the hand
  • Procedure: bioadhesive
    using bioadhesive on simple lacerations of the hand
  • Active Comparator: 1
    suturing lacerations of the hand
    Intervention: Procedure: suturing laceration
  • Active Comparator: 2
    using bioadhesive on lacerations of hand
    Intervention: Procedure: bioadhesive
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
200
Not Provided
Not Provided

Inclusion Criteria:

  • Any age
  • Hand laceration distal to the volar wrist crease.

Exclusion Criteria:

  • Fracture , tendon, artery involvement, more than 8 hours from laceration to trx,
  • Immunosuppression
  • Anticoagulation therapy
  • Diabetes
  • Unable to achieve homeostasis in more than 15 minutes
  • Unwilling to participate in the study
  • Unable to participate in the follow up or bite of any kind.
Both
Not Provided
No
Israel
 
NCT00524888
sutvsglu-HMO-CTIL
Not Provided
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Michael Icekson, MD Hadassah Medical Organization
Hadassah Medical Organization
August 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP